Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Mohsin Badat, a Clinical Training Research Fellow from the Higgs and Davies Groups has been awarded the ASH-BSH Abstract Achievement Award by the American Society of Haematology and the British Society of Haematology.

Headshot of Dr Mohsin Badat. © Created on Canva Pro Account

The award recognises the abstract titled ‘Base Editing Repairs the HbE Mutation Restoring the Production of Normal Globin Chains in Severe HbE/β-Thalassemia Patient Hematopoietic Stem Cells and Erythroid Cells’ which was submitted to the 63rd ASH Annual Meeting and Exposition.

The ASH-BSH Abstract Achievement Award is an annual award celebrating trainees with the highest scoring abstracts at the meeting, of which they are first or senior author.

'I'm very grateful to the American Society of Hematology and the British Society for Haematology for this generous joint award.' says Dr Badat. 'The stipend will allow me to travel to the American Society of Hematology's annual meeting this year in Atlanta, where I will have the opportunity to present our recent progress in developing a base editing cure for HbE/beta-thalassaemia to the wider international haematology community. I hope that through this we will be able to collaborate with others in the field to help bring our approach into the clinical arena.'

Dr Badat will present during the Oral and Poster Abstracts session taking place on the evening of Sunday the 12th December 2021. 

Many Congratulations to Dr Badat!

Similar stories

Project funding for personalised childhood cancer treatments

Funding from the Azaylia Foundation will support the Scientific Advances for Infant Leukaemia (SAIL) programme.

MRC National Mouse Genetics Network Research Clusters Announced

Claus Nerlov and Steve Twigg from the MRC WIMM join the new national network for disease modelling.

From ‘Ew, gross!’ to ‘Wow!’: Scientists bring immunology to the classroom

For British Science Week, members of the MRC WIMM visited a local Oxfordshire primary school for an interactive science day – one of the first of its kind since the start of the pandemic.

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.

Study links the onset of circulation to changes in metabolism affecting blood stem cell development

A new paper published in Cell Reports by the de Bruijn Group indicates that the onset of circulation triggers a metabolic switch associated with the maturation of haematopoietic stem cells.